UVA researchers found that continuous glucose monitor data can predict nerve, eye, and kidney damage from type 1 diabetes.

Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying ...

Researchers at UVA have developed computer models to create targeted antibiotics, aiming to combat antibiotic resistance.

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

Discover Nuvia wPrime 2A Media, the advanced mixed-mode resin by Bio-Rad for efficient biomolecule purification at small to ...

Enhance compliance and quality in the health and wellness market with Eurofins' GMP certification programme for dietary and ...

Discover key considerations for executing workflows in drug discovery, from defining research questions and generating ...

LB Pharmaceuticals announced positive Phase II results for LB-102, showing significant symptom improvement in schizophrenia with a favourable safety profile. LB Pharmaceuticals, a clinical-stage ...

UVA Center for Diabetes Technology and Tandem Diabetes Care partner to advance automated insulin delivery systems for diabetes management. The University of Virginia Center for Diabetes Technology and ...

Macrocycles outperform traditional therapeutics on several fronts, yet they account for just four percent of FDA-approved drugs. Colleagues Ann E Cleves and Ajay N Jain from Optibrium Ltd explain why ...

Researchers have identified early molecular changes in Rett syndrome that could lead to improved treatments for the condition. Scientists investigating the severe developmental disorder known as Rett ...

Researchers at the Medical University of South Carolina have discovered a key genetic mechanism that could lead to RNA-based therapies for psychiatric disorders triggered by emotional experiences.